Economic Evaluation of Multiple Sclerosis in the UK, Germany and France
- 1 January 1998
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 13 (5) , 607-622
- https://doi.org/10.2165/00019053-199813050-00013
Abstract
A cross-sectional cost-of-care study was performed to assess the economic burden of multiple sclerosis (MS) in France, Germany and the UK. Patients were stratified into 3 groups according to the...Keywords
This publication has 21 references indexed in Scilit:
- Disability indices, the economic costs of illness, and social insurance: The case of multiple sclerosisActa Neurologica Scandinavica, 2009
- Quality of life in multiple sclerosis in France, Germany, and the United KingdomJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Multiple sclerosis: it epidemiological, genetic, and health care impact.Journal of Epidemiology and Community Health, 1995
- Use and misuse of statistics for epidemiological studies of multiple sclerosisAnnals of Neurology, 1994
- A cost utility analysis of treatment options for gallstone disease: Methodological issues and resultsHealth Economics, 1994
- Private versus social opportunity cost of time: Valuing time in the demand for health careHealth Economics, 1994
- Health care costs of veterans with multiple sclerosis: implications for the rehabilitation of MS. VA Multiple Sclerosis Rehabilitation Study Group.1993
- Economic status of families living with multiple sclerosisInternational Journal of Rehabilitation Research, 1992
- The prevalence of multiple sclerosis in the Southampton and South West Hampshire Health Authority.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- The Role of Disease and Demographic Factors in the Employment of Patients With Multiple SclerosisArchives of Neurology, 1982